Issue Date: October 24, 2016
Attaching ‘unlinkable’ drugs to antibodies
Attaching a small-molecule drug to a targeting agent such as an antibody can improve the delivery of the drug. A common way to achieve that with antibodies is using a linker that connects to the drug through an amide or carbamate functional group. But tertiary and heteroaryl amines common to many drug molecules lack a place for such a connection, leading researchers to deem them “unlinkable.” A team led by Thomas H. Pillow of Genentech . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society